J. Munoz

发表

Effect of preoperative aspirin use on mortality in coronary artery bypass grafting patients.

J. Birkmeyer, B. Leavitt, J. Morton, 2000, The Annals of thoracic surgery.

Is epsilon-aminocaproic acid as effective as aprotinin in reducing bleeding with cardiac surgery?: a meta-analysis.

J. Birkmeyer, N. Birkmeyer, L. J. Dacey, 1999, Circulation.

Hepatic acetylator polymorphism in breast cancer patients.

C. Jara, G. Pérez-Manga, J. Ladero, 1987, Oncology.

Reexploration for hemorrhage following coronary artery bypass grafting: incidence and risk factors. Northern New England Cardiovascular Disease Study Group.

J. Birkmeyer, W. Nugent, B. Leavitt, 1998, Archives of surgery.

Polymorphic oxidation of debrisoquine in women with breast cancer.

A. Llerena, C. Jara, J. Benítez, 1991, Oncology.

CYP2D6 genotypes in Spanish women with breast cancer.

J. Benítez, J. Agúndez, J. Ladero, 1996, Cancer letters.

Reexploration for Hemorrhage Following Coronary Artery Bypass GraftingIncidence and Risk Factors

J. Birkmeyer, W. Nugent, B. Leavitt, 2000 .

Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery22The views expressed herein do not necessarily represent those of the Department of Veterans Affairs or the United States government.

J. Birkmeyer, N. Birkmeyer, B. Westbrook, 1999 .

The retained penile prosthesis reservoir: a risk.

P. Ellsworth, J. Munoz, 2000, Urology.

Trends in rates of reexploration for hemorrhage after coronary artery bypass surgery. Northern New England Cardiovascular Disease Study Group.

J. Birkmeyer, N. Birkmeyer, B. Westbrook, 1999, The Annals of thoracic surgery.

Is ε-Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? A Meta-Analysis

John D. Birkmeyer, J. Birkmeyer, N. Birkmeyer, 1999 .

Is (cid:101) -Aminocaproic Acid as Effective as Aprotinin in Reducing Bleeding With Cardiac Surgery? A Meta-Analysis

J. Birkmeyer, N. Birkmeyer, L. J. Dacey, 1998 .

A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer.

John W. Scott, D. Sjoberg, D. Parekh, 2015, European urology.

Oxidative polymorphism of debrisoquine in Parkinson's disease.

F. Jiménez-Jiménez, A. Llerena, J. Cobaleda, 1990, Journal of neurology, neurosurgery, and psychiatry.

Polymorphic oxidation of debrisoquine in lung cancer patients.

A. Llerena, C. Jara, J. A. Carrillo, 1991, European journal of cancer.

Polymorphic oxidation of debrisoquine in bladder cancer.

A. Llerena, J. Cobaleda, J. Benítez, 1990, Annals of medicine.

Acetylator polymorphism in Parkinson's disease

A. Llerena, J. Cobaleda, J. Benítez, 2004, European Journal of Clinical Pharmacology.

Upper tract urothelial neoplasms: incidence and survival during the last 2 decades.

L. Ellison, J. J. Muñoz, J. Munoz, 2000, The Journal of urology.